MedTrace Logo

Cell Therapy in Failure Syndromes in Limbal Stem Cells

NCT01619189 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 14

Last updated 2019-09-03

No results posted yet for this study

Summary

Transplantation of allogeneic or autologous limbal epithelial stem cells cultured on human amniotic membrane with no feeders in eyes with total limbal deficiency. Prospective non-comparative monocentric study.

Conditions

  • Limbal Deficiency

Interventions

BIOLOGICAL

epithelial stem cells cultured

transplantation of allogeneic or autologous limbal epithelial stem cells cultured on human amniotic membrane with no feeders

PROCEDURE

transplantation of cultured cells

transplantation of allogeneic or autologous limbal epithelial stem cells cultured on human amniotic membrane with no feeders

Sponsors & Collaborators

  • Etablissement Français du Sang

    collaborator OTHER

  • Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts

    lead OTHER

Principal Investigators

  • Vincent M Borderie, MD, PhD · CHNO des 15-20

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-06-30
Primary Completion
2017-03-06
Completion
2017-03-06

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01619189 on ClinicalTrials.gov